ProSomnus Receives Additional U.S. Utility Patent Covering Iterative Titration Technology for Companys Novel Precision Sleep Apnea Medical Devices
| OSADelisted Stock | 0.47 0.00 0.00% |
About 56% of ProSomnus, Common's investor base is looking to short. The analysis of current outlook of investing in ProSomnus, Common Stock suggests that many traders are alarmed regarding ProSomnus, Common's prospects. The current market sentiment, together with ProSomnus, Common's historical and current headlines, can help investors time the market. In addition, many technical investors use ProSomnus, Common Stock stock news signals to limit their universe of possible portfolio assets.
ProSomnus, |
PLEASANTON, Calif., April 05, 2023 -- ProSomnus, Inc. , a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea , today announced that the U.S. Patent and Trademark Office issued U.S. patent serial number 11,617,677 on April 4, 2023, an addition to a portfolio of several issued U.S. patents covering the Companys iterative titration technology featured in its FDA-cleared and patient-preferred Precision
Read at finance.yahoo.com
 |
ProSomnus, Common Fundamental Analysis
We analyze ProSomnus, Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ProSomnus, Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ProSomnus, Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
ProSomnus, Common is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
ProSomnus, Common Stock Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ProSomnus, Common stock to make a market-neutral strategy. Peer analysis of ProSomnus, Common could also be used in its relative valuation, which is a method of valuing ProSomnus, Common by comparing valuation metrics with similar companies.
Peers
ProSomnus, Common Related Equities
| NPCE | Neuropace | 5.67 | ||||
| ITGR | Integer Holdings | 1.72 | ||||
| LUNG | Pulmonx Corp | 1.23 | ||||
| KIDS | Orthopediatrics Corp | 0.96 | ||||
| AORT | Artivion | 0.20 | ||||
| OFIX | Orthofix Medical | 0.16 | ||||
| ELMD | Electromed | 0.03 | ||||
| IRMD | Iradimed | 0.17 | ||||
| SRDX | SurModics | 0.30 | ||||
| ANIK | Anika Therapeutics | 1.14 | ||||
| LIVN | LivaNova PLC | 1.28 | ||||
| CNMD | CONMED | 1.36 | ||||
| TMCI | Treace Medical | 2.62 | ||||
| CVRX | CVRx | 3.09 | ||||
| ESTA | Establishment Labs | 3.41 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in ProSomnus, Stock
If you are still planning to invest in ProSomnus, Common Stock check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ProSomnus, Common's history and understand the potential risks before investing.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |